Live Breaking News & Updates on Syncona Limited Stock Exchange|Page 3

Stay updated with breaking news from Syncona limited stock exchange. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Syncona (LON:SYNC) Trading Down 0.7%

Syncona Limited (LON:SYNC – Get Rating)’s stock price was down 0.7% during mid-day trading on Monday . The stock traded as low as GBX 148 ($1.83) and last traded at GBX 149.60 ($1.85). Approximately 246,026 shares traded hands during mid-day trading, a decline of 61% from the average daily volume of 635,156 shares. The stock […] ....

Syncona Limited , Get Rating , Syncona Daily , Lon Sync , Computer And Technology ,

Syncona : Appoints Roel Bulthuis as Managing Partner

Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life science, today announces the appointment of Roel Bulthuis as Managing Partner and Head. | April 5, 2023 ....

Eteläuomen Läi , Noord Holland , Chris Hollowood , Roel Bulthuis , Merck Serono , Msc In Biopharmaceutical Sciences , Syncona Investment Management , Helsinki School Of Economics , Merck Group , Syncona Ltd , Fortis Bank , Leiden University , Managing Partner , Inkef Capital , Senior Vice President , Managing Director , Biopharmaceutical Sciences , Helsinki School , Syncona Investment Management Limited , Syncona Limited Stock Exchange , Press Release , Nd Bact Gg00b8p59c08 ,

Syncona leads GBP22.5 million financing in Mosaic

Syncona Ltd - healthcare company focused on a portfolio of global leaders in life science - Leads GBP22.5 million Series A financing in Mosaic Therapeutics, a Cambridge England-based oncology. | April 4, 2023 ....

United Kingdom , Jeremy Cutler , Alliance News , Alliance News Ltd , Freeline Therapeutics Holdings , Syncona Ltd , Mosaic Therapeutics , Cambridge England Based , Cambridge Innovation , Gaucher Disease , All Rights , Syncona Limited Stock Exchange , Press Release , Ambridge Bact Gg00b8p59c08 ,

Novel drug-discovery approach lands big backers

UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare diseases. ....

Scott Biller , Ros Deegan , Dame Carol Robinson , Diana Bernstein , Shouti Pharmaceuticals , Oxford Science Enterprises , Oxford University , United Kingdom Based , Sanofi Ventures , Northpond Ventures , Google Ventures , Laia Crespo , Jeantet Prize , Franklin Medal , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors ,

Forcefield Therapeutics launches today following £5.5m commitment from Syncona

Forcefield Therapeutics launches today following £5.5m commitment from Syncona New biotechnology company launched to develop pioneering, best-in-class therapeutics to protect ....

United Kingdom , City Of , Richard Francis , Amber Fennell , Genevieve Wilson , Jessica Hodgson , Chris Hollowood , Mauro Giacca , King College London , Syncona Investment Management , International Centre For Genetic Engineering , Forcefield Therapeutics Ltd , School Of Cardiovascular Medicine , Syncona Ltd , Consilium Strategic Communications , Professor Mauro Giacca , Cardiovascular Medicine , Professor Giacca , International Centre , Genetic Engineering , Chief Executive Officerof Forcefield Therapeutics , Forcefield Therapeutic , Chief Investment Officer , Syncona Investment Management Limited ,